CASI
CASI Pharmaceuticals Inc
NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY
$0.21
+0.00% today
Updated 2026-04-29
Market cap
$3.21M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$0 – $3
Volume
1.0M
CASI Pharmaceuticals Inc (CASI) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-36.5%
Last 4 quarters
Revenue YoY growth
-60.5%
Most recent quarter
EPS YoY growth
-23.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-10.9%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-10.9%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-14 | $-0.68 | -13.3% | $1.34 | $1.19 | -10.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.60 | $-0.68 | -13.3% | $3.08M | -60.5% |
| 2025-06-30 | $-0.47 | $-0.86 | -83.0% | $4.17M | +4.9% |
| 2025-03-31 | $-0.61 | $-0.69 | -13.1% | $6.24M | +83.0% |
| 2024-12-31 | $0.03 | $-0.75 | -2600.0% | $13.36M | +94.3% |
| 2024-09-30 | $-0.62 | $-0.55 | +11.3% | $7.79M | -11.8% |
| 2024-06-30 | $-0.63 | $-0.55 | +12.7% | $3.98M | -59.5% |
| 2024-03-31 | $-0.05 | $-0.71 | -1320.0% | $3.41M | -59.2% |
| 2023-12-31 | $-0.24 | $-0.45 | -87.5% | $6.87M | -55.0% |
| 2023-09-30 | $-0.56 | $-0.35 | +37.5% | $8.84M | — |
| 2023-06-30 | $-0.50 | $-0.77 | -54.0% | $9.82M | — |
| 2023-03-31 | $-0.64 | $-0.45 | +29.7% | $8.35M | — |
| 2022-12-31 | $-0.37 | $-1.44 | -289.2% | $15.26M | — |
Frequently asked questions
Has CASI Pharmaceuticals Inc beaten earnings estimates?
CASI Pharmaceuticals Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -36.5% over the last 3 quarters.
How does CASI stock react to earnings?
CASI stock has moved an average of -10.9% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.
What is CASI Pharmaceuticals Inc's revenue growth rate?
CASI Pharmaceuticals Inc reported year-over-year revenue growth of -60.5% in its most recent quarter, with EPS growing -23.6% year-over-year.